Quinolones sensitize gram-negative bacteria to antimicrobial peptides

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 7, 2006, Pages 2361-2367

  Campos, Miguel A ^a   Morey, Pau ^a   Bengoechea, José A ^a,b,c  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Program Infection and Immunity   (Spain)

^c Hospital Joan March   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DEFENSIN; DEFENSIN 1; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE PERMEABILITY; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; QUINOLONES;

EID: 33745597122     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01437-05     Document Type: Article

References (42)

1. Bengoechea, J. A., R. Díaz, and I. Moriyón. 1996. Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect. Immun. 64:4891-4899.
2. Bengoechea, J. A., B. Lindner, U. Seydel, R. Díaz, and I. Moriyón. 1998. Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica. Microbiology 144:1509-1515.
3. Brazas, M. D., and R. E. Hancock. 2005. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3222-3227.
4. Breines, D. M., and J. C. Burnham. 1994. Modulation of Escherichia coli type 1 fimbrial expression and adherence to uroepithelial cells following exposure of logarithmic phase cells to quinolones at subinhibitory concentrations. J. Antimicrob. Chemother. 34:205-221.
5. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
6. Campos, M. A., M. A. Vargas, V. Regueiro, C. M. Llompart, S. Alberti, and J. A. Bengoechea. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72:7107-7114.
7. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
8. Deguchi, T., T. Kawamura, M. Yasuda, M. Nakano, H. Fukuda, H. Kato, N. Kato, Y. Okano, and Y. Kawada. 1997. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob. Agents Chemother. 41:1609-1611.
9. Doss, S. A., G. S. Tillotson, and S. G. Amyes. 1993. Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus. J. Appl. Bacteriol. 75:123-128.
10. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
11. Finlay, B. B., and R. E. Hancock. 2004. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2:497-504.
12. Gallo, R. L., M. Murakami, T. Ohtake, and M. Zaiou. 2002. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110:823-831.
13. Gmuender, H., K. Kuratli, K. Di Padova, C. P. Gray, W. Keck, and S. Evers. 2001. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis. Genome Res. 11:28-42.
14. Groisman, E. A. 1994. How bacteria resist killing by host-defence peptides. Trends Microbiol. 2:444-449.
15. Gunn, J. S., K. B. Lim, J. Krueger, K. Kim, L. Guo, M. Hackett, and S. I. Miller. 1998. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27:1171-1182.
16. Gunn, J. S., and S. I. Miller. 1996. Pho-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol. 178:6857-6864.
17. Gunn, J. S., S. S. Ryan, J. C. Van Velkinburgh, R. K. Ernst, and S. I. Miller. 2000. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 68:6139-6146.
18. Guo, L., K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and S. I. Miller. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phop-phoQ. Science 276:250-253.
19. Guo, L., K. B. Lim, C. M. Poduje, M. Daniel, J. S. Gunn, M. Hackett, and S. I. Miller. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198.
20. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
21. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
22. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
23. Hermsen, E. D., C. J. Sullivan, and J. C. Rotschafer. 2003. Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications. Infect. Dis. Clin. N. Am. 17:545-562.
24. Lecomte, S., M. H. Baron, M. T. Chenon, C. Coupry, and N. J. Moreau. 1994. Effect of magnesium complexation by fluoroquinolones on their antibacterial properties. Antimicrob. Agents Chemother. 38:2810-2816.
25. Lindner, B., A. Wiese, K. Brandenburg, U. Seydel, and A. Dalhoff. 2002. Lack of interaction of fluoroquinolones with lipopolysaccharides. Antimicrob. Agents Chemother. 46:1568-1570.
26. Loh, B., C. Grant, and R. E. W. Hancock. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551.
27. Loubeyre, C., J. F. Desnottes, and N. Moreau. 1993. Influence of subinhibitory concentrations of antibacterials on the surface properties and adhesion of Escherichia coli. J. Antimicrob. Chemother. 31:37-45.
28. Luck, P. C., J. W. Schmitt, A. Hengerer, and J. H. Helbig. 1998. Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens. Antimicrob. Agents Chemother. 42:2870-2876.
29. Marshall, A. J., and L. J. Piddock. 1994. Interaction of divalent cations, quinolones and bacteria. J. Antimicrob. Chemother. 34:465-483.
30. Martinez-Martinez, L., I. Garcia, S. Ballesta, V. J. Benedi, S. Hernandez-Alles, and A. Pascual. 1998. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 42:1850-1852.
31. Martinez-Martinez, L., A. Pascual, M. C. Conejo, I. Garcia, P. Joyanes, A. Domenech-Sanchez, and V. J. Benedi. 2002. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production. Antimicrob. Agents Chemother. 46:3926-3932.
32. Moore, R. A., N. C. Bates, and R. E. Hancock. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29:496-500.
33. Moore, R. A., and R. E. Hancock. 1986. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30:923-926.
34. Nassif, X., J. M. Fournier, J. Arondel, and P. J. Sansonetti. 1989. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect. Immun. 57:546-552.
35. Newton, B. A. 1955. A fluorescent derivative of polymyxin: its preparation and use in studying the site of action of the antibiotic. J. Gen. Microbiol. 12:226-236.
36. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defence system of vertebrates. Annu. Rev. Microbiol. 49:277-304.
37. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
38. Peschel, A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10:179-186.
39. Sawyer, J. G., N. L. Martin, and R. E. Hancock. 1988. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 56:693-698.
40. Trancassini, M., M. I. Brenciaglia, M. C. Ghezzi, P. Cipriani, and F. Filadoro. 1992. Modification of Pseudomonas aeruginosa virulence factors by sub-inhibitory concentrations of antibiotics. J. Chemother. 4:78-81.
41. Vaara, M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
42. Vranes, J., Z. Zagar, and S. Kurbel. 1996. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated Escherichia coli. J. Chemother. 8:254-260.